Bedfordshire and Luton Joint Prescribing Committee
Ref: JPC Bulletin 277
Bulletin Date: 01/10/20
Review Date: September 2022
Safinamide for Parkinson’s Disease – Bulletin 277
A Formulary application for Safinamide for the treatment of Parkinson’s Disease was considered at the September 2019 JPC meeting.
Following discussion, the Committee decided not to support the Formulary application for safinamide. The main concerns were the lack of head to head trials with appropriate comparators, safety issues (e.g. retinopathy) and cost/cost-effectiveness.